An authoritative technical blueprint for clinical researchers, healthcare enterprises, and AI developers procuring non-contact facial biofeedback sensors to quantify human emotion, stress, valence, and psychological resilience in continuous real-world environments.
Validated & Recognized By Leading Publications
.png){kind=logo}
.png){kind=logo}
.png)
.png)
The global digital health and clinical research landscape is undergoing a fundamental transformation. For over a decade, enterprise healthcare organizations, pharmaceutical clinical trial managers, and affective computing researchers relied on first-generation biometric wearables—primarily wrist-based Photoplethysmography (PPG) for Heart Rate Variability (HRV), Galvanic Skin Response (GSR/EDA), and skin temperature sensors. While valuable for measuring systemic autonomic nervous system arousal, these conventional metrics suffer from a critical diagnostic limitation: an inability to distinguish valence (positive vs. negative emotional states) and high vulnerability to physical motion artifacts.
When an individual experiences a surge in heart rate or skin conductance, traditional sensors cannot determine whether the underlying driver is physical exertion, acute anxiety, cognitive overload, joy, or frustration. This ambiguity severely limits their utility in decentralized clinical trials (DCTs), occupational mental health tracking, psychiatric biofeedback, and real-time AI digital therapeutics.
To establish true clinical utility, modern procurement requirements have pivoted toward multi-modal sensing platforms capable of directly capturing central-nervous-system-driven facial muscle activations. Optomyography (OMG)—a patented optical skin-displacement sensing modality pioneered by Emteq Labs—overcomes the physical constraints of traditional surface Electromyography (sEMG) and camera-based facial coding. By measuring micro-structural skin movements in three dimensions without skin-contact electrodes or outward privacy-invading facial cameras, wearable mental health monitoring sensors embedded in ergonomic eyewear offer unedited, real-time insight into human affective state, stress resilience, and cognitive fatigue in everyday, ecologically valid environments.
.avif)
The world’s first integrated wearable mental health monitoring sensor platform engineered specifically for continuous, contact-free facial biofeedback and behavioral analytics.
OCOsense™ integrates a proprietary array of non-contact Optomyography (OMG) sensors within a lightweight, stylish eyeglass form factor. Unlike bulky laboratory equipment or invasive adhesive electrodes, OCOsense™ allows subjects to go about their daily routines while continuously capturing physiological responses to environmental, emotional, and cognitive stressors.
Global procurement teams evaluating wearable mental health monitoring sensors require rigorous technical benchmarks. Below is the engineering specification matrix for the OCOsense™ platform:
| Parameter | OCOsense™ Sensor Specification | Clinical & Enterprise Benefit |
|---|---|---|
| Primary Biosensing Modality | Patented OCO™ Optomyography (OMG) | Non-contact 3D optical skin displacement measurement; zero skin preparation or gel required. |
| Facial Muscle Coverage | Corrugator, Zygomaticus, Orbicularis, Frontalis regions | Direct quantification of emotional valence (positive vs. negative) and mental workload. |
| Inertial Tracking | 9-Axis IMU (Accelerometer, Gyroscope, Magnetometer) + Altimeter | Correlates emotional spikes with physical movement, posture shifts, and ambulatory context. |
| Contextual Telemetry | Outward HD Scene Camera (1080p, timestamped) | Provides exact "why" context behind physiological changes without capturing facial identities. |
| Sampling Rate & Latency | Up to 100 Hz synchronized data streaming (<1 ms edge processing latency) | Enables real-time closed-loop biofeedback and immediate digital therapeutic intervention. |
| Data Privacy Architecture | On-Device Vectorization (No raw facial imagery stored) | Complete compliance with HIPAA, GDPR, and institutional review board (IRB) requirements. |
| Connectivity & SDK | Bluetooth Low Energy (BLE 5.2), Wi-Fi, Open C++/Python SDK | Seamless integration into enterprise cloud architecture, custom iOS/Android applications, and AI pipelines. |
| Regulatory Approvals | CE Mark, RoHS, WEEE compliant; ISO 13485 quality control framework | Accelerates approval timelines for clinical studies and commercial medical device deployment. |
Hardware excellence is only half of the solution. Emteq Labs provides a complete end-to-end machine learning analytics platform that translates raw optomyographic waveforms into validated behavioral and mental health digital biomarkers.
Our algorithms continuously map facial muscle activation patterns to established psychological frameworks (such as the Circumplex Model of Affect). By combining 3D facial movement dynamics with physical activity classification, enterprise users can isolate genuine psychological distress from routine daily tasks.
Strategic insights for enterprise buyers, clinical research organizations (CROs), and medical technology procurement leads navigating the next 5 years of affective sensing innovation.
Enterprise procurement strategies are moving away from single-metric devices toward multi-modal sensing suites. The future belongs to hybrid architectures combining non-contact optical muscle tracking (OMG), inertial motion telemetry, and peripheral autonomic signals. This multi-layered approach eliminates signal ambiguity and dramatically increases diagnostic accuracy in unconstrained settings.
With increasing regulatory scrutiny surrounding biometric data (GDPR, CCPA, HIPAA), enterprise buyers are refusing platforms that upload raw video or facial photos to central servers. Procurement guidelines now mandate on-device feature extraction where bio-signal vectors are derived locally, ensuring zero exposure of personally identifiable visual data.
Pharmaceutical sponsors are aggressively procuring wearable mental health monitoring sensors for Phase II–IV decentralized clinical trials. The ability to passively gather continuous psychiatric data while patients remain in their home environments reduces patient drop-out rates by up to 40% and provides ecological validity that traditional in-clinic paper questionnaires (such as PHQ-9 or GAD-7) cannot match.
As conversational AI therapy agents and adaptive mental health apps mature, they require real-time physiological feedback loops to adjust interventions dynamically. Modern procurement specifications demand low-latency Bluetooth connectivity and open APIs so AI models can read a patient’s valence and stress level in real time and modify therapeutic prompts accordingly.
Procurement departments are setting higher barrier-to-entry standards. Consumer-grade fitness trackers are no longer considered acceptable for clinical-grade applications. Vendors must demonstrate ISO 13485 quality management systems, CE marking, electrical safety compliance, and clear pathways toward FDA Software as a Medical Device (SaMD) authorization.
Understanding the engineering breakthroughs transforming wearable mental health sensing over the coming decade.
Sub-Millimeter Optical Motion Sensing: Optomyography replaces delicate gel electrodes with micro-optical sensors that detect mechanical skin displacement through clothing or frame contacts without causing skin irritation or signal degradation over extended wear periods.
Context-Aware Inertial Fusion: Coupling 9-axis IMUs with altimeters allows algorithms to filter out motion artifacts caused by walking, head movement, or swallowing, maintaining pristine biosensor accuracy even during physical exertion.
Environmental Context Synchronization: Integrated outward scene video cameras map physiological emotional reactions directly to specific visual stimuli (e.g., social interactions, media consumption, workplace tasks) for accurate root-cause analysis.
Ultra-Low Power Edge Inference: Embedded neuromorphic microcontrollers execute machine learning models locally on the frame, drastically cutting energy consumption and enabling full-day continuous operational battery life.
Answers to key technical, regulatory, and integration queries frequently submitted by global procurement teams and researchers.
Wrist-worn HRV (PPG) and Galvanic Skin Response (GSR) measure autonomic nervous system activity, which reflects general physiological arousal but lacks valence specificity. A elevated heart rate can indicate excitement, physical exertion, fear, or anger. In contrast, Optomyography (OMG) optical sensors measure micro-displacements of facial muscles controlled by cranial nerves directly connected to emotional processing centers in the brain. OMG allows precise discrimination between positive (smiling/zygomatic) and negative (frowning/corrugator) valence, delivering an order-of-magnitude higher signal specificity for mental health research.
Data privacy is embedded in our hardware architecture. Unlike webcams or head-mounted video cameras that record recognizable images of the user's face, OCOsense sensors utilize non-contact optical sensors oriented inward toward skin contour points. Signal conversion occurs locally on-device via our edge analytics engine, outputting abstract mathematical vectors (muscle activation levels, movement indices) rather than visual imagery. No facial video streams are created or stored, ensuring total alignment with GDPR, HIPAA, and institutional ethics review standards.
Emteq Labs provides an open, robust software suite including native mobile data collection applications (iOS/Android), an open C++/Python SDK, and REST API access. Data can be recorded locally or streamed in real time via Bluetooth Low Energy (BLE) or Wi-Fi. Export formats include time-synchronized CSV, JSON, and HDF5 files containing raw optical sensor telemetry, 9-axis IMU metrics, timestamped scene video, and processed affective indices.
Yes. We offer commercial procurement packages ranging from standard developer evaluation kits to custom OEM hardware modifications, firmware integration, and co-developed algorithm training. Our engineering team works closely with enterprise partners to configure frame ergonomics, sensor placement, and cloud database connectors for specific clinical trial protocols or commercial wellness programs.
Emteq Labs operates under strict ISO 13485 quality management systems for medical devices. OCOsense hardware complies fully with CE mark requirements, RoHS, and WEEE directives. The platform is designed to provide validated surrogate endpoint data for decentralized clinical trials and digital therapeutic submission pathways with regulatory bodies such as the FDA and EMA.
Standard developer evaluation kits and research bundles are typically dispatched within 5 to 10 business days depending on order volume and destination country. Enterprise bulk procurement and custom OEM integration projects follow tailored delivery schedules agreed upon during technical scoping. Contact our sales team using the link below to verify current inventory status.
Built on over a decade of groundbreaking research in facial neuroscience, affective computing, and optical biosensing engineering.
Founded by renowned facial surgeons, psychiatrists, and neuroscientists, Emteq Labs was born from a clinical mandate: to create precise, non-invasive diagnostic tools for facial paralysis rehabilitation, psychiatric evaluation, and emotional biofeedback.
Our core Optomyography (OMG) sensing modalities and wearable frames are backed by an extensive global patent portfolio (including GB2561537, GB2604076, US11,003,899, and US11,538,279), guaranteeing exclusive technological superiority for our enterprise partners.
Our hardware and algorithmic models are continuously validated through collaborative research programs with top tier institutions including Northeastern University, University of Sussex, University of Portsmouth, University of Glasgow, and Jožef Stefan Institute.
Partner with the global leader in wearable optomyography sensors. Speak directly with our bio-engineering and clinical research specialists to scope your enterprise procurement, clinical trial, or OEM integration requirement.
OCO™ and OCOsense™ are trademarks of Emteq Limited. Covered by granted patents GB2561537, GB2604076, US11,003,899, US11,538,279 and international pending applications. All rights reserved.